Cluster Headache
A primary headache disorder that is characterized by severe, strictly unilateral PAIN which is orbital, supraorbital, temporal or in any combination of these sites, lasting 15-180 min. occurring 1 to 8 times a day. The attacks are associated with one or more of the following, all of which are ipsilateral: conjunctival injection, lacrimation, nasal congestion, rhinorrhea, facial SWEATING, eyelid EDEMA, and miosis. (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)
Drugs by status
Approved for this indication (8)
Phase 4 trials (3)
Phase 3 trials (9)
Phase 2 trials (9)
Phase 1 trials (3)
Organizations
Organization Involved with Phase 4 Indications (8)
Organization Involved with Phase 3 Indications (13)
- Eli Lilly
- Teva
- Winston Laboratories
- Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
- University of London
- Norwegian University of Science and Technology
- Klinik Barmelweid
- Clinic Barmelweid AG
- University of Texas at Houston
- University of Duisburg-Essen
- University of Paris
- Lundbeck
- Catholic University of Valencia
Organization Involved with Phase 2 Indications (7)
Organization Involved with Phase 1 Indications (5)
Organization Involved with Other Experimental Indications (4)